(NEPH) Nephros - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US6406714005

NEPH EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of NEPH over the last 5 years for every Quarter.

NEPH Revenue

This chart shows the Revenue of NEPH over the last 5 years for every Quarter.

NEPH: Water Filtration, Ultrafiltration, Biofilm Reduction

Nephros Inc. is a commercial-stage company that specializes in providing innovative water solutions to various markets, including medical, commercial, and industrial sectors in the United States. Their product portfolio includes ultrafiltration systems and water filters designed to remove a wide range of contaminants, such as bacteria, viruses, and heavy metals, from water. The companys products are used in diverse settings, including dialysis centers, hospitals, military facilities, and commercial establishments, to improve water quality and prevent infections. With a strong focus on delivering high-quality products, Nephros has established itself as a reliable player in the water treatment industry.

Analyzing the companys market presence and product offerings, it is evident that Nephros has a diversified customer base across various industries. Their ultrafiltration products are particularly relevant in the medical sector, where water purity is critical for patient care. Additionally, their water filters are designed to enhance the taste and odor of water, making them suitable for commercial and hospitality markets. With a growing emphasis on water quality and safety, Nephros is well-positioned to capitalize on the increasing demand for its products.

Examining the , we observe that NEPHs stock price has been trending upwards, with a current price of $2.63, above its SMA20 and SMA50. The ATR indicates a relatively moderate volatility of 5.58%. Considering the , the companys Market Cap stands at $22.79M, with a P/E ratio of 26.88, suggesting a moderate valuation. The RoE of 9.43% indicates a decent return on equity. Based on these metrics, we can forecast that NEPHs stock price may continue to rise in the short term, driven by its improving financials and growing demand for its products. A potential price target could be around $3.20, representing a 22% increase from the current price.

To achieve this forecast, Nephros will need to continue executing on its growth strategy, expanding its customer base, and increasing its market share in the water treatment industry. The companys ability to innovate and adapt to changing market conditions will be crucial in driving its future success. With its strong product portfolio and diversified customer base, Nephros is well-positioned to capitalize on the growing demand for water treatment solutions, potentially driving its stock price higher in the coming months.

Additional Sources for NEPH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

NEPH Stock Overview

Market Cap in USD 40m
Sector Healthcare
Industry Medical Instruments & Supplies
GiC Sub-Industry Household Appliances
IPO / Inception 2004-09-21

NEPH Stock Ratings

Growth Rating -40.3
Fundamental 66.2
Dividend Rating 0.0
Rel. Strength 94.7
Analysts 4.5 of 5
Fair Price Momentum 3.92 USD
Fair Price DCF 0.88 USD

NEPH Dividends

Currently no dividends paid

NEPH Growth Ratios

Growth Correlation 3m 88.6%
Growth Correlation 12m 13.6%
Growth Correlation 5y -58.9%
CAGR 5y -13.77%
CAGR/Max DD 5y -0.15
Sharpe Ratio 12m -0.06
Alpha 87.91
Beta -0.761
Volatility 63.60%
Current Volume 49.9k
Average Volume 20d 52.2k
What is the price of NEPH shares?
As of June 30, 2025, the stock is trading at USD 3.86 with a total of 49,943 shares traded.
Over the past week, the price has changed by -10.02%, over one month by +46.77%, over three months by +124.42% and over the past year by +82.94%.
Is Nephros a good stock to buy?
Yes, based on ValueRay´s Fundamental Analyses, Nephros (NASDAQ:NEPH) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 66.22 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of NEPH is around 3.92 USD . This means that NEPH is currently overvalued and has a potential downside of 1.55%.
Is NEPH a buy, sell or hold?
Nephros has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy NEPH.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for NEPH share price target?
According to our own proprietary Forecast Model, NEPH Nephros will be worth about 4.2 in June 2026. The stock is currently trading at 3.86. This means that the stock has a potential upside of +9.59%.
Issuer Target Up/Down from current
Wallstreet Target Price 4.8 23.1%
Analysts Target Price 4.8 23.1%
ValueRay Target Price 4.2 9.6%